0001209191-23-041689.txt : 20230706 0001209191-23-041689.hdr.sgml : 20230706 20230706190248 ACCESSION NUMBER: 0001209191-23-041689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230703 FILED AS OF DATE: 20230706 DATE AS OF CHANGE: 20230706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tipirneni Praveen P. CENTRAL INDEX KEY: 0001779978 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38940 FILM NUMBER: 231074852 MAIL ADDRESS: STREET 1: C/O MORPHIC HOLDING, INC., STREET 2: 35 GATEHOUSE DRIVE, A2 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Morphic Holding, Inc. CENTRAL INDEX KEY: 0001679363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473878772 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 9787296480 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE A2 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Morphic Holding, LLC DATE OF NAME CHANGE: 20160712 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-03 0 0001679363 Morphic Holding, Inc. MORF 0001779978 Tipirneni Praveen P. C/O MORPHIC HOLDING, INC. 35 GATEHOUSE DRIVE, A2 WALTHAM MA 02451 1 1 0 0 President and CEO 0 Common Stock 2023-07-03 4 M 0 3597 4.32 A 17533 D Common Stock 2023-07-03 4 S 0 3597 57.0413 D 13936 D Stock Option (right to buy Common Stock) 4.32 2023-07-03 4 M 0 3597 0.00 D 2028-12-14 Common Stock 3597 364740 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder dated September 16, 2022. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.61 to $57.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option is fully vested. /s/ Robert Farrell as attorney-in-fact for Praveen P. Tipirneni 2023-07-06